Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 10
2003 8
2004 12
2005 10
2006 10
2007 14
2008 14
2009 14
2010 16
2011 22
2012 21
2013 28
2014 19
2015 14
2016 21
2017 25
2018 19
2019 19
2020 21
2021 20
2022 23
2023 24
2024 17
2025 27
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

395 results

Results by year

Filters applied: . Clear all
Page 1
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C, Rimashevskaya E, Pika T, Gaidano G, Weisel K, Goranova-Marinova V, Schwarer A, Minuk L, Masszi T, Karamanesht I, Offidani M, Hungria V, Spencer A, Orlowski RZ, Gillenwater HH, Mohamed N, Feng S, Chng WJ; ENDEAVOR Investigators. Dimopoulos MA, et al. Lancet Oncol. 2016 Jan;17(1):27-38. doi: 10.1016/S1470-2045(15)00464-7. Epub 2015 Dec 5. Lancet Oncol. 2016. PMID: 26671818 Free article. Clinical Trial.
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Mateos MV, et al. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231133 Free article. Clinical Trial.
TFR2-Related Hemochromatosis.
De Gobbi M, Roetto A. De Gobbi M, et al. 2005 Aug 29 [updated 2023 Dec 7]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. 2005 Aug 29 [updated 2023 Dec 7]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. PMID: 20301523 Free Books & Documents. Review.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
[Moschkowitz's disease].
Varaldo R, Gobbi M. Varaldo R, et al. Among authors: gobbi m. Ann Ital Med Int. 2005 Apr-Jun;20(2):69-70. Ann Ital Med Int. 2005. PMID: 16052838 Review. Italian. No abstract available.
Juvenile hemochromatosis.
Camaschella C, Roetto A, De Gobbi M. Camaschella C, et al. Among authors: de gobbi m. Semin Hematol. 2002 Oct;39(4):242-8. doi: 10.1053/shem.2002.35635. Semin Hematol. 2002. PMID: 12382199 Review.
SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA.
Germani S, Van Ho AT, Cherubini A, Varone E, Chernorudskiy A, Renna GM, Fumagalli S, Gobbi M, Lucchetti J, Bolis M, Guarrera L, Craparotta I, Rastelli G, Piccoli G, de Napoli C, Nogara L, Poggio E, Brini M, Cattaneo A, Bachi A, Simmen T, Calì T, Quijano-Roy S, Boncompagni S, Blaauw B, Ferreiro A, Zito E. Germani S, et al. Among authors: gobbi m. Cell Rep Med. 2024 Mar 19;5(3):101439. doi: 10.1016/j.xcrm.2024.101439. Epub 2024 Feb 22. Cell Rep Med. 2024. PMID: 38402623 Free PMC article.
Nonlinear transport in non-centrosymmetric systems.
Suárez-Rodríguez M, de Juan F, Souza I, Gobbi M, Casanova F, Hueso LE. Suárez-Rodríguez M, et al. Among authors: gobbi m. Nat Mater. 2025 Jul;24(7):1005-1018. doi: 10.1038/s41563-025-02261-3. Epub 2025 Jun 20. Nat Mater. 2025. PMID: 40542234 Review.
Natural history of juvenile haemochromatosis.
De Gobbi M, Roetto A, Piperno A, Mariani R, Alberti F, Papanikolaou G, Politou M, Lockitch G, Girelli D, Fargion S, Cox TM, Gasparini P, Cazzola M, Camaschella C. De Gobbi M, et al. Br J Haematol. 2002 Jun;117(4):973-9. doi: 10.1046/j.1365-2141.2002.03509.x. Br J Haematol. 2002. PMID: 12060140 Review.
Nonvolatile Electric Control of Antiferromagnet CrSBr.
Jo J, Mañas-Valero S, Coronado E, Casanova F, Gobbi M, Hueso LE. Jo J, et al. Among authors: gobbi m. Nano Lett. 2024 Apr 17;24(15):4471-4477. doi: 10.1021/acs.nanolett.4c00348. Epub 2024 Apr 8. Nano Lett. 2024. PMID: 38587318
395 results